Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells

Clinical and Experimental Metastasis

Volumn 21, Issue 4, 2004, Pages 285-292

  Okada, Yuji ^a   Eibl, Guido ^a   Guha, Sushovan ^a   Duffy, John P ^a   Reber, Howard A ^a   Hines, Oscar J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

MMP 2; MT1 MMP; NGF; pancreatic cancer; perineural invasion

Indexed keywords

GELATINASE A; NERVE GROWTH FACTOR;

ARTICLE; CANCER CELL; CANCER INVASION; CELL ACTIVITY; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROTEIN EXPRESSION; REGULATORY MECHANISM;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; NERVE GROWTH FACTOR; PANCREATIC NEOPLASMS; RECEPTOR, TRKA;

EID: 7244238297     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CLIN.0000046131.24625.54     Document Type: Article

References (25)

1. Jemal A, Thomas A, Murray T et al. Cancer statistics, 2002. CA Cancer J Clin 2002; 52 (1): 23-47.
2. Hirai I, Kimura W, Ozawa K et al. Perineural invasion in pancreatic cancer. Pancreas 2002; 24 (1): 15-25.
3. Ozaki H, Hiraoka T, Mizumoto R et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 1999; 29 (1): 16-22.
4. Takahashi T, Ishikura H, Motohara T et al. Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol 1997; 65 (3): 164-70.
5. Ketterer K, Rao S, Friess H et al. Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res 2003; 9 (14): 5127-36.
6. Marchetti D, Menter D, Jin L et al. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 1993; 55 (4): 692-9.
7. Nicolson GL, Menter DG, Herrmann JL et al. Brain metastasis: Role of trophic, autocrine, and paracrine factors in tumor invasion and colonization of the central nervous system. Curr Top Microbiol Immunol 1996; 213 (Pt 2) 89-115.
8. Sariola H. The neurotrophic factors in non-neuronal tissues. Cell Mol Life Sci 2001; 58 (8): 1061-6.
9. Vidaltamayo R, Mery CM, Angeles-Angeles A et al. Expression of nerve growth factor in human pancreatic beta cells. Growth Factors 2003; 21 (3-4): 103-7.
10. Okada Y, Takeyama H, Sato M et al. Experimental implication of celiac ganglionotropic invasion of pancreatic-cancer cells bearing c-ret proto-oncogene with reference to glial-cell-line-derived neurotrophic factor (GDNF). Int J Cancer 1999; 81 (1): 67-73.
11. Okada Y, Eibl G, Duffy JP et al. Glial cell-derived neurotrophic factor upregulates the expression and activation of matrix metalloproteinase-9 in human pancreatic cancer. Surgery 2003; 134 (2): 293-9.
12. Zhu Z, Kleeff J, Kayed H et al. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells. Mol Carcinog 2002; 35 (3): 138-47.
13. Zhu ZW, Friess H, Wang L et al. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 2001; 7 (1): 105-12.
14. Cox G, O'Byrne KJ. Matrix metalloproteinases and cancer. Anticancer Res 2001; 21 (6B): 4207-19.
15. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17 463-516.
16. Gong YL, Xu GM, Huang WD et al. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer. J Surg Oncol 2000; 73 (2): 95-9.
17. Gress TM, Muller-Pillasch F, Lerch MM et al. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 1995; 62 (4): 407-13.
18. Nagase H. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res 1998; 8 (3): 179-86.
19. Geldof AA, Van Haarst EP, Newling DW. Neurotrophic factors in prostate and prostatic cancer. Prostate Cancer Prostatic Dis 1998; 1 (5): 236-41.
20. Dolle L, Yazidi-Belkoura I, Adriaenssens E et al. Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 2003; 22 (36): 5592-601.
21. Yamamoto H, Itoh F, Iku S et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: Clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol 2001; 19 (4): 1118-27.
22. Yang X, Staren ED, Howard JM et al. Invasiveness and MMP expression in pancreatic carcinoma. J Surg Res 2001; 98 (1): 33-9.
23. Koshiba T, Hosotani R, Wada M et al. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 1998; 82 (4): 642-50.
24. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 1994; 218 (2): 325-9.
25. Miknyoczki SJ, Lang D, Huang L et al. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: Expression patterns and effects on in vitro invasive behavior. Int J Cancer 1999; 81 (3): 417-27.